Isabelle François is a strategic development and partnerships leader with over 20 years of experience at the intersection of healthcare, logistics, and innovation. Known for her ability to bring together diverse stakeholders around a shared purpose, she specialises in building financially sustainable ecosystems where science, infrastructure and patient outcomes converge.
Isabelle currently leads four ambitious initiatives. At Brussels Airport, she serves as project coordinator for the Precision Therapies Logistics Gateway (PTLG), a pioneering effort to build international logistics corridors capable of handling the most sensitive, patient-specific therapies in medicine today, from cell and gene therapies to radioligand treatments. Her focus extends beyond infrastructure to the business case that makes it scalable and future-proof. She also contributes to VirusBank Platform, a KU Leuven initiative developing a permanent toolbox for pandemic preparedness, where she is responsible for creating the financial frameworks that will ensure its long-term viability. At the University Hospital Antwerp, she coordinates the development of a joint research team bringing together three leading research groups in developmental disorders, with the ambition of maximising patient impact over the next decade while securing a sustainable foundation for future researchers. Through PULSE, a collaborative project involving an investment firm Noshaq, a university and a university hospital, she is shaping the content and tenant strategy for two new healthcare buildings, once again anchoring visionary ambitions in solid, sustainable business planning.
Isabelle is co-chair of the healthcare community at XR Valley, chair of the external advisory board of the KU Leuven Digital Society Institute, strategic advisor at the Greenhouse (innovation hub of AZ Groeninge, a major Belgian hospital) and strategic advisor of the start-up Okono.
Across all of her work, Isabelle is guided by a simple but powerful conviction: that the best outcomes for patients are achieved not through competition, but through carefully designed collaboration — and that lasting impact requires structures built to endure.
I'm speaking at:
Panel Discussion: Priorities & Best Practices for Shipping Precision Therapies
An expert discussion on the logistical frontiers required to support the latest generation of medicines, including radioligands, mRNA vaccines, Cell & Gene Biologics, and ATMPs.
Copenhagen 2026 2026-10-06 14:40-15:30